Inventor · disambiguated record
Peter David Davis
Also filed as: DAVIS PETER D · DAVIS PETER DAVID
25 granted patents·10 pending applications·1,975 citations·filing 1989–2013
97Inventor score
Files withANGIOGENE PHARM LTD11CELLTECH THERAPEUTICS LTD9HOFFMANN LA ROCHE4CELLTECH R&D LTD3ASTRAZENECA AB2
Top patents by PatentIndex Score
35 records- 0198US6235746B1Substituted 2-anilinopyrimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1999·Granted May 22, 2001·290 cites·12 claims
- 0298US6093716ASubstituted 2-pyrimidineamines and processes for their preparationCELLTECH THERAPEUTICS LTD·Filed 1997·Granted Jul 25, 2000·267 cites·7 claims
- 0398US5958935ASubstituted 2-anilinopyrimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1996·Granted Sep 28, 1999·361 cites·23 claims
- 0497US6337335B1Substituted 2-anilinopyrimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1999·Granted Jan 8, 2002·105 cites·20 claims
- 0597US5057614ASubstituted pyrrolesHOFFMANN LA ROCHE·Filed 1989·Granted Oct 15, 1991·208 cites·12 claims
- 0694US6048866ASubstituted 2-anilinopryimidines useful as protein kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1998·Granted Apr 11, 2000·113 cites·10 claims
- 0792US6599908B1Fused polycyclic 2-aminopyrimidine derivativesCELLTECH R&D LTD·Filed 2000·Granted Jul 29, 2003·47 cites·11 claims
- 0892US6114333A2-Pyrimidineamine derivatives and processes for their preparationCELLTECH THERAPEUTICS LTD·Filed 1997·Granted Sep 5, 2000·103 cites·6 claims
- 0991US5292747ASubstituted pyrrolesHOFFMANN LA ROCHE·Filed 1992·Granted Mar 8, 1994·76 cites·24 claims
- 1089US7789175B2Modular dual wheel drive assembly, wheeled devices that include modular dual wheel drive assemblies and methods for moving and/or maneuvering wheeled devices using modular dual wheel drive assembliesCYCOGS LLC·Filed 2005·Granted Sep 7, 2010·52 cites·20 claims
- 1186US6057329AFused polycyclic 2-aminopyrimidine derivativesCELLTECH THERAPEUTICS LTD·Filed 1997·Granted May 2, 2000·63 cites·15 claims
- 1285US5721245A4- 3-indolyl!-1H-pyrroloneHOFFMANN LA ROCHE·Filed 1995·Granted Feb 24, 1998·72 cites·18 claims
- 1384US5922741A5-aminopyrazoles useful as tyrosine kinase inhibitorsCELLTECH THERAPEUTICS LTD·Filed 1997·Granted Jul 13, 1999·60 cites·16 claims
- 1483US7875727B2Benzimidazole vascular damaging agentsANGIOGENE PHARM LTD·Filed 2006·Granted Jan 25, 2011·4 cites·31 claims
- 1583US6906048B2N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activityASTRAZENECA AB·Filed 2001·Granted Jun 14, 2005·22 cites·9 claims
- 1683US6552029B12-pyrimidineamine derivatives and processes for their preparationCELLTECH R&D LTD·Filed 1999·Granted Apr 22, 2003·58 cites·13 claims
- 1777US6645950B1Benzimidazole vascular damaging agentsANGIOGENE PHARM LTD·Filed 2000·Granted Nov 11, 2003·8 cites·6 claims
- 1876US7087627B1Combinations for the treatment of diseases involving angiogenesisANGIOGENE PHARM LTD·Filed 2000·Granted Aug 8, 2006·7 cites·19 claims
- 1976USRE36736ESubstituted pyrrolesHOFFMANN LA ROCHE·Filed 1998·Granted Jun 13, 2000·21 cites·14 claims
- 2071US7105501B2Compositions with vascular damaging activityANGIOGENE PHARM LTD·Filed 2003·Granted Sep 12, 2006·6 cites·14 claims
- 2169US7265136B1Substituted stilbene compounds with vascular damaging activityANGIOGENE PHARM LTD·Filed 2000·Granted Sep 4, 2007·4 cites·17 claims
- 2266US6133257AFused polycyclic 2-aminopyrimidine derivativesCELLTECH THERAPEUTICS LTD·Filed 1998·Granted Oct 17, 2000·23 cites·9 claims
- 2364US7081469B2Benzimidazole vascular damaging agentsANGIOGENE PHARM LTD·Filed 2003·Granted Jul 25, 2006·1 cites·14 claims
- 2453US2007021392A1Divided dose therapies with vascular damaging activityDAVIS PETER D·Filed 2005·Application pending·0 cites
- 2552US2006198846A1Combinations for the treatment of diseases involving angiogenesisANGIOGENE PHARM LTD·Filed 2006·Application pending·0 cites
- 2651US2005107346A1N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activityASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2751US2006128633A1Colchinol derivatives as vascular damaging agentsANGIOGENE PHARM LTD·Filed 2005·Application pending·0 cites
- 2847US7012076B2Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinasesCELLTECH R&D LTD·Filed 2001·Granted Mar 14, 2006·0 cites·4 claims
- 2943US2015141349A1Method and Composition for Alleviating Tumor SymptomsANGIOGENE PHARM LTD·Filed 2013·Application pending·0 cites
- 3042US7135502B1Colchinol derivatives as vascular damaging agentsANGIOGENE PHARM LTD·Filed 1999·Granted Nov 14, 2006·4 cites·13 claims
- 3140US2006223827A1Bioreductively activated stilbene prodrugsSIEMENS AG·Filed 2004·Application pending·0 cites
- 3240US2003055024A1Divided dose therapies with vascular damaging activityFiled 2001·Application pending·0 cites
- 3338US2007099871A1Bioreductively-activated prodrugsGRAY LAB CANCER RES TRUST·Filed 2004·Application pending·0 cites
- 3437US2008145372A1Bioreductively-Activated ProdrugsANGIOGENE PHARM LTD·Filed 2005·Application pending·0 cites
- 3535US2009202571A1Bioreductively-activated prodrugsHOPNIC LAB CO LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter David Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →